Dr. Suleiman Fageeh Hospital – Jeddah has achieved a new medical milestone by performing the first autologous stem cell transplant in the private sector of Saudi Arabia, for a 55-year-old patient with multiple myeloma. This step reflects the advancement of specialized services in hematology and oncology and strengthens the hospital's position as a leading center for advanced healthcare.

The hospital's stem cell transplant and cell therapy program launched its first procedure by performing an autologous stem cell transplant for the patient, and the operation was successful, confirming the program's readiness to provide this type of precise treatment according to the latest international medical standards and protocols. Dr. Mazen Fageeh, Chairman of the Fageeh Healthcare Group, affirmed that this achievement represents a qualitative step in the group's journey towards providing the latest specialized medical services, reflecting its ongoing commitment to delivering advanced healthcare according to best international practices, contributing to enhancing the quality of healthcare within the Kingdom.

Autologous stem cell transplantation is a cornerstone in treating medically eligible multiple myeloma patients. It involves collecting stem cells from the patient after initial treatment, then administering high doses of chemotherapy to eliminate as many cancer cells as possible, before reinfusing the stem cells to rebuild bone marrow and accelerate blood cell recovery. This technique deepens treatment response, prolongs disease control, and improves therapeutic outcomes and patient quality of life. Dr. Ahmed Al-Saeed, Consultant Hematologist and Bone Marrow Transplant at Dr. Suleiman Fageeh Hospital – Jeddah, explained that the success of the first autologous stem cell transplant within the stem cell transplant and cell therapy program reflects the hospital's readiness in terms of medical expertise and specialized equipment, allowing patients to receive this advanced treatment within the Kingdom according to the highest international standards.

It is worth noting that the Oncology Center at Dr. Suleiman Fageeh Hospital – Jeddah is among the advanced centers providing comprehensive and integrated cancer care, from early diagnosis through treatment to follow-up. The center includes a multidisciplinary team of oncology surgeons, medical oncologists, radiation oncologists, histopathologists, specialized nursing staff, psychological support services, and nutritional therapy. The team operates under a tumor board model, where each case is discussed to determine the most appropriate treatment plan.

The center offers a wide range of advanced services, including complex and precise oncological surgeries, laparoscopic and robotic oncological surgeries, chemotherapy, immunotherapy, targeted therapy, and radiation therapy with the latest technologies, in addition to early detection programs, comprehensive screenings, and psychological and rehabilitation support services for cancer patients and their families.

This achievement underscores the advanced standing of Dr. Suleiman Fageeh Hospital – Jeddah in providing specialized care for oncology and hematology patients, reflecting the readiness of its infrastructure and medical expertise to deliver advanced treatments according to best international practices, thereby enhancing the quality of healthcare provided to patients.